These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6132863)

  • 1. Effect of somatostatin on liver blood flow in the rat.
    MacLellan DG; Shulkes A; Hardy KJ
    Horm Res; 1983; 17(2):103-7. PubMed ID: 6132863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in portal vein blood flow by somatostatin.
    Jaspan J; Polonsky K; Lewis M; Moossa AR
    Diabetes; 1979 Oct; 28(10):888-92. PubMed ID: 478183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
    Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
    Cerini R; Lee SS; Hadengue A; Koshy A; Girod C; Lebrec D
    Gastroenterology; 1988 Mar; 94(3):703-8. PubMed ID: 2892752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels.
    Romeo JM; Novo C; Fernández-Cruz A; Lòpez-Novoa JM
    Heart Vessels; 1990; 5(4):219-23. PubMed ID: 1977734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
    Kravetz D; Bosch J; Arderiu MT; Pizcueta MP; Casamitjana R; Rivera F; Rodés J
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G322-8. PubMed ID: 2894777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of blood flow in rat liver with Xenon-133.
    Bolmsjö M; Hafström L; Hugander A; Persson B
    Int J Microcirc Clin Exp; 1983; 2(1):27-37. PubMed ID: 6678837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clearance of Xenon-133 following its parenchymal injection: a rapid method for estimating functional liver blood-flow.
    Jenkins SA; Taylor A; Shimirty SK; Johnson J; Baxter JN; Taylor I; Shields R
    Clin Physiol; 1985 Oct; 5(5):433-42. PubMed ID: 4053526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Feng H; Li S; Gan L; Zhang Y; Du R
    Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):433-5. PubMed ID: 11825434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-induced cholestasis can be independent of portal blood flow.
    Kortz WJ; Meyers WC; Schirmer BD; Jones RS
    Surgery; 1983 May; 93(5):649-52. PubMed ID: 6133363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogue (SMS 201-995) but not somatostatin reduces indocyanine green clearance in the portal hypertensive rat.
    Kimchi N; Krepel Z; Ronen E; Bar-Meir E; Bruck R; Bar-Meir S
    Isr J Med Sci; 1993 Jan; 29(1):37-9. PubMed ID: 8095929
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
    Barbare JC; Poupon R; Jaillon P; Bories P; Aussanaire M; Darnis F; Michel H; Cheymol G
    Hepatology; 1984; 4(1):59-62. PubMed ID: 6141135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory effects of somatostatin in anesthetized man.
    Tydén G; Samnegård H; Thulin L; Muhrbeck O; Efendić S
    Acta Chir Scand; 1979; 145(7):443-46. PubMed ID: 161458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.